Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
An announcement from Veradigm ( (MDRX) ) is now available.
On January 28, 2025, Elizabeth A. Altman resigned from Veradigm’s Board of Directors, including her roles as Chair and member of the Audit Committee, due to health reasons. Her resignation, which was not due to any disagreements with the company, led to the appointment of P. Gregory Garrison as the interim Chair of the Audit Committee, and a reduction in the Board’s size. Additionally, Veradigm concluded its exploration of strategic alternatives, announced an operational review, and plans to provide business updates in mid-March 2025.
More about Veradigm
Veradigm is a healthcare technology company that offers a combination of platforms, data, expertise, connectivity, and scale. The Veradigm Network provides advanced insights, technology, and data-driven solutions for healthcare providers, payers, and the biopharma markets.
YTD Price Performance: -16.37%
Average Trading Volume: 399,114
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $1.36B
See more insights into MDRX stock on TipRanks’ Stock Analysis page.
